Lilly Signs Deals With Dexcom, Glooko, myDiabby, Roche For Diabetes Management Solutions
Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.
You may also be interested in...
The market for blood glucose monitoring devices is expected to see double-digit growth, reaching $19.7bn by 2025. This growth is driven largely by the rising demand for smaller, more convenient continuous glucose monitoring (CGMs) devices with improved digital capabilities.
The deal is part of Medtronic's ongoing strategy to revive its diabetes business with technology that simplifies insulin delivery.
Glooko entered a partnership to integrate Companion Medical's InPen insulin data into Glooko's diabetes management systems.